$2.42 Billion is the total value of BVF INC/IL's 80 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 8.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MOONLAKE IMMUNOTHERAPEUTICSclass a ord | $173,140,000 | +51.6% | 21,751,284 | 0.0% | 7.15% | +29.7% | ||
| IONS | Buy | IONIS PHARMACEUTICALS INC | $127,071,000 | +168.9% | 2,872,953 | +125.1% | 5.25% | +130.0% |
| GHRS | GH RESEARCH PLCordinary shares | $107,777,000 | +16.4% | 9,275,158 | 0.0% | 4.45% | -0.4% | |
| KYMR | Buy | KYMERA THERAPEUTICS INC | $102,158,000 | +25.4% | 4,692,604 | +13.4% | 4.22% | +7.2% |
| RPTX | REPARE THERAPEUTICS INC | $100,582,000 | -13.3% | 8,291,988 | 0.0% | 4.16% | -25.8% | |
| RLAY | Sell | RELAY THERAPEUTICS INC | $97,075,000 | +32.2% | 4,339,521 | -1.0% | 4.01% | +13.1% |
| CGEM | CULLINAN ONCOLOGY INC | $96,266,000 | 0.0% | 7,509,059 | 0.0% | 3.98% | -14.5% | |
| RLMD | Buy | RELMADA THERAPEUTICS INC | $76,936,000 | +144.2% | 2,078,220 | +25.3% | 3.18% | +108.8% |
| CRNX | CRINETICS PHARMACEUTICALS IN | $72,255,000 | +5.3% | 3,678,947 | 0.0% | 2.98% | -9.9% | |
| RCUS | Sell | ARCUS BIOSCIENCES INC | $71,077,000 | -29.2% | 2,717,020 | -31.4% | 2.94% | -39.4% |
| MRUS | Sell | MERUS N V | $68,992,000 | -25.3% | 3,444,420 | -15.6% | 2.85% | -36.1% |
| New | THIRD HARMONIC BIO INC | $66,429,000 | – | 3,501,814 | +100.0% | 2.74% | – | |
| XOMA | Buy | XOMA CORP DEL | $64,682,000 | -17.8% | 3,611,494 | +2.3% | 2.67% | -29.7% |
| RVMD | Buy | REVOLUTION MEDICINES INC | $64,200,000 | +46.0% | 3,255,588 | +44.3% | 2.65% | +24.9% |
| ACRS | ACLARIS THERAPEUTICS INC | $62,591,000 | +12.8% | 3,976,543 | 0.0% | 2.59% | -3.5% | |
| CTIC | Sell | CTI BIOPHARMA CORP | $51,292,000 | -3.8% | 8,813,021 | -1.3% | 2.12% | -17.7% |
| IDYA | Buy | IDEAYA BIOSCIENCES INC | $49,159,000 | +27.5% | 3,294,859 | +17.9% | 2.03% | +9.0% |
| KURA | KURA ONCOLOGY INC | $43,764,000 | -25.5% | 3,203,783 | 0.0% | 1.81% | -36.2% | |
| SNDX | Sell | SYNDAX PHARMACEUTICALS INC | $43,208,000 | -4.7% | 1,798,085 | -23.7% | 1.78% | -18.5% |
| PNT | Buy | POINT BIOPHARMA GLOBAL INC | $43,211,000 | +88.4% | 5,590,048 | +66.0% | 1.78% | +61.1% |
| Sell | CINCOR PHARMA INC | $43,074,000 | +39.0% | 1,312,443 | -20.2% | 1.78% | +18.9% | |
| LXRX | Buy | LEXICON PHARMACEUTICALS INC | $38,758,000 | +47.3% | 16,149,179 | +14.1% | 1.60% | +26.0% |
| VRDN | Sell | VIRIDIAN THERAPEUTICS INC | $35,725,000 | +77.0% | 1,741,840 | -0.1% | 1.48% | +51.5% |
| ITOS | Sell | ITEOS THERAPEUTICS INC | $34,496,000 | -13.2% | 1,810,835 | -6.1% | 1.42% | -25.7% |
| XENE | Sell | XENON PHARMACEUTICALS INC | $32,530,000 | -33.1% | 901,095 | -43.6% | 1.34% | -42.8% |
| NUVALENT INC | $32,393,000 | +43.4% | 1,666,282 | 0.0% | 1.34% | +22.6% | ||
| FDMT | 4D MOLECULAR THERAPEUTICS IN | $32,220,000 | +15.2% | 4,007,413 | 0.0% | 1.33% | -1.5% | |
| COGT | Sell | COGENT BIOSCIENCES INC | $31,106,000 | +52.8% | 2,084,824 | -7.6% | 1.28% | +30.7% |
| ALLK | New | ALLAKOS INC | $30,642,000 | – | 5,006,921 | +100.0% | 1.27% | – |
| Sell | EQRX INC | $29,741,000 | -40.4% | 6,008,187 | -43.6% | 1.23% | -49.0% | |
| AN2 THERAPEUTICS INC | $28,098,000 | +124.3% | 1,616,665 | 0.0% | 1.16% | +91.9% | ||
| CNTA | CENTESSA PHARMACEUTICALS PLCsponsored ads | $27,715,000 | -17.5% | 6,894,345 | 0.0% | 1.14% | -29.4% | |
| CNCE | CONCERT PHARMACEUTICALS INC | $24,314,000 | +59.1% | 3,629,000 | 0.0% | 1.00% | +36.0% | |
| ACIU | AC IMMUNE SA | $23,474,000 | -12.5% | 7,428,379 | 0.0% | 0.97% | -25.1% | |
| ANNX | ANNEXON INC | $23,365,000 | +63.9% | 3,780,694 | 0.0% | 0.96% | +40.3% | |
| VERV | New | VERVE THERAPEUTICS INC | $22,328,000 | – | 650,000 | +100.0% | 0.92% | – |
| TYRA BIOSCIENCES INC | $21,732,000 | +22.9% | 2,472,327 | 0.0% | 0.90% | +5.2% | ||
| OLMA | OLEMA PHARMACEUTICALS INC | $21,008,000 | -32.2% | 7,611,503 | 0.0% | 0.87% | -42.0% | |
| JANX | JANUX THERAPEUTICS INC | $19,908,000 | +10.9% | 1,470,334 | 0.0% | 0.82% | -5.2% | |
| STRO | SUTRO BIOPHARMA INC | $19,136,000 | +6.5% | 3,447,946 | 0.0% | 0.79% | -9.0% | |
| ETNB | Sell | 89BIO INC | $18,202,000 | +45.0% | 3,143,682 | -19.4% | 0.75% | +24.1% |
| RAIN | RAIN THERAPEUTICS INC | $17,210,000 | -12.2% | 3,526,729 | 0.0% | 0.71% | -24.9% | |
| VSTM | VERASTEM INC | $16,978,000 | -26.7% | 19,974,658 | 0.0% | 0.70% | -37.4% | |
| New | VIGIL NEUROSCIENCE INC | $16,504,000 | – | 1,813,633 | +100.0% | 0.68% | – | |
| REPL | REPLIMUNE GROUP INC | $16,001,000 | -1.2% | 926,529 | 0.0% | 0.66% | -15.5% | |
| EPIX | Buy | ESSA PHARMA INC | $15,923,000 | +36.7% | 8,748,629 | +136.5% | 0.66% | +16.9% |
| VIRX | VIRACTA THERAPEUTICS INC | $15,435,000 | +10.1% | 3,614,662 | 0.0% | 0.64% | -5.8% | |
| SLN | Buy | SILENCE THERAPEUTICS PLCads | $14,888,000 | +88.5% | 1,508,416 | +126.3% | 0.62% | +61.0% |
| OVID | OVID THERAPEUTICS INC | $12,606,000 | -14.4% | 6,851,051 | 0.0% | 0.52% | -26.7% | |
| AADI BIOSCIENCE INC | $12,421,000 | +14.7% | 879,085 | 0.0% | 0.51% | -1.9% | ||
| CALT | CALLIDITAS THERAPEUTICS ABsponsered ads | $11,325,000 | -16.0% | 750,000 | 0.0% | 0.47% | -28.1% | |
| CTMX | Buy | CYTOMX THERAPEUTICS INC | $9,564,000 | -10.0% | 6,595,801 | +13.6% | 0.40% | -23.0% |
| IKNA | IKENA ONCOLOGY INC | $8,886,000 | -19.9% | 2,503,071 | 0.0% | 0.37% | -31.5% | |
| ALPN | Sell | ALPINE IMMUNE SCIENCES INC | $8,179,000 | -24.6% | 1,135,940 | -10.9% | 0.34% | -35.5% |
| INFI | INFINITY PHARMACEUTICALS INC | $7,561,000 | +88.2% | 6,353,645 | 0.0% | 0.31% | +60.8% | |
| Sell | HILLEVAX INC | $6,536,000 | +56.3% | 382,452 | -0.0% | 0.27% | +33.7% | |
| ELDN | ELEDON PHARMACEUTICALS INC | $6,422,000 | +13.1% | 2,326,710 | 0.0% | 0.26% | -3.3% | |
| PIRS | PIERIS PHARMACEUTICALS INC | $5,842,000 | -38.5% | 5,080,320 | 0.0% | 0.24% | -47.5% | |
| PYXIS ONCOLOGY INC | $5,790,000 | -17.2% | 2,938,851 | 0.0% | 0.24% | -29.3% | ||
| GLYC | GLYCOMIMETICS INC | $5,266,000 | -7.7% | 9,544,262 | 0.0% | 0.22% | -21.0% | |
| CDTX | CIDARA THERAPEUTICS INC | $4,309,000 | +28.6% | 6,861,127 | 0.0% | 0.18% | +9.9% | |
| SPRO | Sell | SPERO THERAPEUTICS INC | $3,859,000 | +68.6% | 1,929,376 | -37.6% | 0.16% | +43.2% |
| MTEM | MOLECULAR TEMPLATES INC | $3,746,000 | -17.8% | 4,996,565 | 0.0% | 0.16% | -29.5% | |
| MOLN | MOLECULAR PARTNERS AGads | $2,970,000 | -0.4% | 443,221 | 0.0% | 0.12% | -14.6% | |
| IVA | INVENTIVA SAads | $2,655,000 | -33.5% | 686,040 | 0.0% | 0.11% | -43.0% | |
| ELEV | ELEVATION ONCOLOGY INC | $2,613,000 | -19.3% | 2,312,200 | 0.0% | 0.11% | -30.8% | |
| SELB | Sell | SELECTA BIOSCIENCES INC | $2,282,000 | +1.1% | 1,391,749 | -19.2% | 0.09% | -13.8% |
| GBIO | Sell | GENERATION BIO CO | $1,921,000 | -81.3% | 361,824 | -76.7% | 0.08% | -84.1% |
| FWP | FORWARD PHARMA A/Ssponsord ads new | $1,516,000 | -31.9% | 513,791 | 0.0% | 0.06% | -41.1% | |
| XFOR | X4 PHARMACEUTICALS INC | $1,450,000 | +77.3% | 847,879 | 0.0% | 0.06% | +50.0% | |
| MEIP | MEI PHARMA INC | $1,365,000 | -36.1% | 3,532,057 | 0.0% | 0.06% | -45.6% | |
| CALITHERA BIOSCIENCES INC | $1,366,000 | +19.5% | 464,742 | 0.0% | 0.06% | +1.8% | ||
| CRVS | CORVUS PHARMACEUTICALS INC | $1,122,000 | -17.3% | 1,370,947 | 0.0% | 0.05% | -30.3% | |
| ALRN | AILERON THERAPEUTICS INC | $1,088,000 | -20.5% | 5,265,555 | 0.0% | 0.04% | -31.8% | |
| ANGN | ANGION BIOMEDICA CORP | $986,000 | -19.2% | 1,071,297 | 0.0% | 0.04% | -30.5% | |
| ERYP | ERYTECH PHARMAsponsored adr | $690,000 | -52.1% | 1,314,656 | 0.0% | 0.03% | -58.6% | |
| BIONOMICS LIMITEDads | $578,000 | +4.1% | 80,971 | 0.0% | 0.02% | -11.1% | ||
| GLMD | GALMED PHARMACEUTICALS LTD | $558,000 | -54.4% | 1,799,694 | 0.0% | 0.02% | -61.0% | |
| RZLT | REZOLUTE INC | $523,000 | -15.1% | 190,815 | 0.0% | 0.02% | -26.7% | |
| CFRX | Sell | CONTRAFECT CORP | $79,000 | -99.4% | 472,300 | -88.1% | 0.00% | -99.5% |
| VYGR | Exit | VOYAGER THERAPEUTICS INC | $0 | – | -140,000 | -100.0% | -0.04% | – |
| CLDX | Exit | CELLDEX THERAPEUTICS INC NEW | $0 | – | -154,000 | -100.0% | -0.20% | – |
| PTGX | Exit | PROTAGONIST THERAPEUTICS INC | $0 | – | -1,106,838 | -100.0% | -0.42% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| XENON PHARMACEUTICALS INC | 36 | Q3 2023 | 4.7% |
| PIERIS PHARMACEUTICALS INC | 30 | Q3 2023 | 2.8% |
| CYTOKINETICS INC | 29 | Q4 2020 | 11.8% |
| INFINITY PHARMACEUTICALS INC | 29 | Q2 2023 | 4.3% |
| XOMA CORP DEL | 28 | Q3 2023 | 7.3% |
| ARQULE INC | 27 | Q4 2019 | 4.8% |
| CHEMOCENTRYX INC | 26 | Q3 2019 | 13.8% |
| CYTOMX THERAPEUTICS INC | 26 | Q3 2023 | 5.3% |
| CORVUS PHARMACEUTICALS INC | 26 | Q3 2023 | 2.3% |
| ARRAY BIOPHARMA INC | 25 | Q2 2019 | 14.5% |
View BVF INC/IL's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 4 | 2024-01-29 |
| 3 | 2024-01-26 |
| 4 | 2024-01-09 |
| 4 | 2023-12-20 |
| 4 | 2023-11-17 |
| 13F-HR | 2023-11-14 |
| 3 | 2023-11-13 |
| 3 | 2023-11-06 |
| 4 | 2023-11-06 |
View BVF INC/IL's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.